RxDoctor Payments Data

Trenay Hart, PA

Physician Assistant · Billings, MTNPI 1013120500

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $48,763 of the $56,648 with a category attached, or 86.1%. AbbVie accounts for 70.4% of it on its own, with 12 other manufacturers making up the rest. Reporting peaked in 2022 at $28,187 and has fallen 73.4% since, to $7,497 in 2024. Among physician assistant clinicians in MT with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$56,648in general payments, 2019–2025

Across 199 payments — averaging $284.66 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$40K
  • Amgen$12K
  • Teva Pharmaceuticals USA, Inc.$2K
  • Livanova USA, Inc.$2K
  • Merz Pharmaceuticals, LLC$285
  • Biohaven Pharmaceutical Holding Company Ltd.$162
  • plus $258 from 7 others

What the payments were for

  • Speaking & faculty fees$48,76386%
  • Travel & lodging$3,5616%
  • Food & beverage$4,2257%
  • Education$1000%

General payments by program year

21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$56,648 in reported general payments places this provider in the 95th percentile of 626 physician assistant providers in Montana.

See all physician assistant providers in Montana

Medicare billing

Part B allowed, 2024
$52,574
Medicare patients
142
Services billed
4,622

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Nurtec OdtRimegepant Sulfate28$64,873
Aimovig AutoinjectorErenumab-Aooe42$49,680
QuliptaAtogepant31$22,818
UbrelvyUbrogepant18$22,092
Emgality PenGalcanezumab-Gnlm20$14,778
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen59$1,835
Sumatriptan Succinate30$1,494
Carbidopa-LevodopaCarbidopa/Levodopa67$1,381
Carbidopa-Levodopa-EntacaponeCarbidopa/Levodopa/Entacapone13$1,141
Carbidopa-Levodopa ErCarbidopa/Levodopa15$661
Gabapentin60$608
Butalbital-Acetaminophen-CaffeButalb/Acetaminophen/Caffeine40$582
Naratriptan Hcl21$570
Morphine Sulfate ErMorphine Sulfate18$535
Levetiracetam25$451

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerNurtec Odt$19$64,87328 claims
AbbVieQulipta, Ubrelvy$39,878$44,90949 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 626 physician assistant providers in Montana.

Other physician assistant in Billings

See the full list for Montana

Where these figures come from

Is this you, or does something look wrong? →